Log in or Sign up for Free to view tailored content for your specialty!
Regulatory/Legislative News
RetroSense Therapeutics secures $6 million in Series A financing
RetroSense Therapeutics has secured $6 million in Series A financing to investigate the use of gene therapy and optogenetics to restore vision loss, according to a press release.
Argus II Retinal Prosthesis System approved in Canada
The Argus II Retinal Prosthesis System has been approved by Health Canada to treat patients with severe to profound outer retinal degeneration, according to a press release from Second Sight Medical Products.
Log in or Sign up for Free to view tailored content for your specialty!
MANF receives orphan drug designation for retinitis pigmentosa
MANF, an investigational drug, has received orphan drug designation for the treatment of retinitis pigmentosa from the U.S. Food and Drug Administration, Amarantus BioScience Holdings announced in a press release.
Rescan 700 intraoperative OCT cleared by FDA
The Rescan 700 intraoperative optical coherence tomography system has received clearance from the U.S. Food and Drug Administration, according to a press release from Carl Zeiss Meditec.
Travatan approved in EU for pediatric glaucoma patients
The European Commission has granted Travatan eye drop solution an additional indication to treat pediatric patients with ocular hypertension or pediatric glaucoma, Alcon announced in a Novartis press release.
FDA approves generic solution of dorzolamide with timolol
The U.S. Food and Drug Administration approved Lannett Company’s abbreviated new drug application for dorzolamide hydrochloride and timolol maleate ophthalmic solution 2%/0.5%.
FDA clears Eidon confocal scanner
The U.S. Food and Drug Administration has cleared the Eidon true-color confocal scanner, according to a press release from CenterVue.
Iluvien granted marketing authorization in the Netherlands
Alimera Sciences announced that marketing authorization has been granted to Iluvien in the Netherlands.
FDA grants priority review to Eylea for diabetic retinopathy in patients with DME
The U.S. Food and Drug Administration has granted priority review for Eylea injection for the treatment of diabetic retinopathy in patients with diabetic macular edema, according to a Regeneron press release.
Four regulatory news updates in ophthalmology
From late October through November, notable regulatory decisions were made by the U.S. Food and Drug Administration, Centers for Medicare and Medicaid Services and the Irish Health Products Regulatory Authority – from recommendations to approve a multifocal toric IOL to positive reimbursement statuses for implants and injections.
-
Headline News
FDA issues limited acne product recalls, AAD releases statement on benzoyl peroxide
March 13, 20254 min read -
Headline News
Sleep duration a predictor of high blood pressure in teens regardless of insomnia
March 14, 20252 min read -
Headline News
Additional support may be key to combat shortages in nephrology workforce
March 10, 20257 min read
-
Headline News
FDA issues limited acne product recalls, AAD releases statement on benzoyl peroxide
March 13, 20254 min read -
Headline News
Sleep duration a predictor of high blood pressure in teens regardless of insomnia
March 14, 20252 min read -
Headline News
Additional support may be key to combat shortages in nephrology workforce
March 10, 20257 min read